Case_id: case_46
Case_description: 
A medical research study is evaluating an investigational novel drug (medication 1) compared with standard therapy (medication 2) in patients presenting to the emergency department with myocardial infarction (MI). The study enrolled a total of 3,000 subjects, 1,500 in each study arm. Follow-up was conducted at 45 days post-MI. The following are the results of the trial:
Endpoints Medication 1 Medication 2 P-Value
Primary: death from cardiac causes 134 210 0.03
Secondary: hyperkalemia 57 70 0.4
What is the number needed to treat (NNT) for the primary endpoint of death from cardiac causes? (Round to the nearest whole number.)
Options: 
1. 5
2. 16
3. 20
4. 30
5. 50
Correct Answer: 20

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 3 (20)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**

- **Study Overview**: A clinical trial enrolled 3,000 patients presenting with myocardial infarction (MI) to the emergency department. Participants were randomized equally into two groups: 1,500 received an investigational novel drug (Medication 1), and 1,500 received standard therapy (Medication 2).
- **Primary Endpoint**: Death from cardiac causes occurred in 134 patients treated with Medication 1 and 210 patients treated with Medication 2.
- **Secondary Endpoint**: Incidence of hyperkalemia was 57 in the Medication 1 group and 70 in the Medication 2 group.
- **Statistical Significance**: The primary endpoint showed a p-value of 0.03, indicating statistical significance, while the secondary endpoint did not (p=0.4).

**2. Analysis of Clinical Features**

- **Primary Endpoint Evaluation**:
  - **Medication 1**: 134 deaths out of 1,500 patients (8.93%).
  - **Medication 2**: 210 deaths out of 1,500 patients (14%).
  - **Absolute Risk Reduction (ARR)**: 14% (Medication 2) - 8.93% (Medication 1) = 5.07%.
- **Number Needed to Treat (NNT)**:
  - **Formula**: NNT = 1 / ARR.
  - **Calculation**: 1 / 0.0507 ≈ 19.74.
  - **Rounded NNT**: 20.
- **Secondary Endpoint**: The difference in hyperkalemia incidence is not statistically significant (p=0.4), thus it does not influence the NNT calculation for the primary endpoint.

**3. Differential Diagnosis Analysis**

While this case pertains to the calculation of NNT rather than a clinical diagnosis, evaluating the options requires understanding the statistical outcome:

- **Option 1: 5** – Impractically low given the ARR of approximately 5%.
- **Option 2: 16** – Closer but still below the calculated NNT.
- **Option 3: 20** – Aligns precisely with the computed NNT of approximately 20.
- **Option 4: 30** – Exceeds the calculated NNT.
- **Option 5: 50** – Significantly higher than the calculated NNT.

Medical guidelines and standard calculations support that with an ARR of approximately 5%, an NNT of around 20 is accurate.

**4. Final Selection**

**My final selection is: Option 3 (20) (二十)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 3 (20)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- A randomized controlled trial compared Medication 1 (investigational drug) versus Medication 2 (standard therapy) in 3,000 patients with myocardial infarction (1,500 per group).  
- The primary endpoint was death from cardiac causes, with 134 deaths in Medication 1 and 210 in Medication 2 at 45 days post-MI.  
- The secondary endpoint (hyperkalemia) showed no significant difference (p=0.4).  

**2. Analysis of Clinical Features**  
- **Primary Endpoint Analysis**:  
  - **Medication 1**: 134/1,500 (8.93% mortality).  
  - **Medication 2**: 210/1,500 (14% mortality).  
  - **Absolute Risk Reduction (ARR)**: 14% - 8.93% = **5.07%**.  
  - **Number Needed to Treat (NNT)**: 1 / ARR = 1 / 0.0507 ≈ **19.72**, rounded to **20**.  
- The p-value of 0.03 confirms statistical significance for the primary endpoint.  
- Hyperkalemia (secondary endpoint) is irrelevant to the NNT calculation for cardiac death.  

**3. Differential Diagnosis Analysis**  
- **Option 1 (5)**: Incorrect. This would imply an ARR of ~20%, which is inconsistent with the observed 5.07% ARR.  
- **Option 2 (16)**: Incorrect. This would require an ARR of ~6.25%, which does not match the calculated 5.07%.  
- **Option 3 (20)**: Correct. Matches the calculated NNT of ~20.  
- **Option 4 (30)**: Incorrect. This would imply an ARR of ~3.3%, which is lower than observed.  
- **Option 5 (50)**: Incorrect. This would require an ARR of ~2%, far below the observed value.  

**4. Final Selection**  
**My final selection is: Option 3 (20)（20）**
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 3 (20)

DeepSeek's full response:
================================================================================
**My final selection is: Option 3 (20)(20)**  

**1. Case Summary and Key Symptoms**  
- The study involves 3,000 myocardial infarction (MI) patients randomized to investigational drug (Medication 1) or standard therapy (Medication 2).  
- Primary endpoint: Death from cardiac causes (Medication 1: 134/1,500 vs. Medication 2: 210/1,500; *p=0.03*).  
- Secondary endpoint: Hyperkalemia (no significant difference, *p=0.4*).  

**2. Analysis of Clinical Features**  
- **Absolute Risk Reduction (ARR):**  
  - Medication 1 risk = 134/1,500 ≈ 8.93%.  
  - Medication 2 risk = 210/1,500 = 14.00%.  
  - ARR = 14.00% - 8.93% = **5.07%** (0.0507 in decimal form).  
- **Number Needed to Treat (NNT):**  
  - NNT = 1 / ARR = 1 / 0.0507 ≈ **19.74**, rounded to **20**.  

**3. Differential Diagnosis Analysis**  
- **Option 3 (20):** Matches the calculated NNT of ~20.  
- Other options (5, 16, 30, 50): Deviate significantly from the computed value.  

**4. Final Selection**  
- **Key Evidence:** ARR of 5.07% directly yields NNT ≈ 20. The p-value (0.03) confirms statistical significance for the primary endpoint.  
**My final selection is: Option 3 (20)(20)**
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 3 (20)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option3

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option3 - 20
Correct Answer: - 20

Is the final diagnosis correct? ✓ Correct

